AsiaOne – August 2018

160 | ASIA ONE | JULY-AUGUST 2018

POWERFUL

E

stablished in 1982

with the core

mission of protecting

consumers’ health

and wellbeing, Synokem

Pharmaceuticals is making

rapid growth with proven

H[SHUWLVH LQ WKH oHOG

of manufacturing and

marketing premium quality

pharmaceutical products

under the pilotage of Chairman

Mr. J.M. Arora and Managing

Director Mr. Abhinav Arora.

SCIENTIFIC TECHNOLOGIES

Having accredited with

:+2*03 &HUWLoFDWLRQ

Synokem manufactures over

100 novel DGCI-approved

pharmaceutical formulations

LQ LWV FHUWLoHG XQLW HTXLSSHG

with state-of-the-art in-

house testing laboratory.

Synokem Pharmaceuticals

is also engaged in Contract

Manufacturing of Finished

Formulations in the form of

Tablets, Capsules, Liquid

Orals, Ointment, Hormonal

Gels, Bi-layered and Sustained

release preparations, which

are being manufactured at its

well-equipped ultra-modern

manufacturing units (3), two

at Haridwar, Uttrakhand and

one at Guwahati, Assam.

These manufacturing units

are WHO-GMP and ISO 9001-

FHUWLoHG

ONLY IN THE WORLD:

Natural Micronized

Progesterone (Sustained

release) tablets.

LATEST ACHIEVEMENTS:

APREMILAST TABLETS,

ULIPRISTAL TABLETS,

DIENOGEST TABLETS,

AZELNIDIPINE TABLETS,

AZILSARTAN TABLETS.

STRONG OVERSEAS

FOOTHOLD

Beginning its export venture

from SAARC countries in 2012,

Synokem Pharmaceuticals

JDLQHG oUVW DSSURYDO IRU LWV

facility from the Sri Lanka

FDA authority (CDDA) and has

been successful in spreading

its operations in Southeast

Asia and recently received

approval from Philippines

FDA, whereas the operations

in Cambodia and Myanmar are

already going on.

The company has expanded

its overseas tie ups in Africa

as well, and accredited with

PPB-Kenya, NDA-Uganda,

FDA-Ghana, NAFDAC-Nigeria

and DPML-Ivory Coast.

It is successfully supplying

its various FDF’s to Nepal,

Bhutan and Afghanistan

too. Synokem has a

remarkable presence in CIS

and is presently operating

in Uzbekistan, Georgia,

Tajikistan, Serbia and

America. LATAM is a latest

venture for Synokem and

Peru, Ecuador, Bolivia and

Chile are its prime markets to

which company is exporting

regularly.

Synokem Pharmaceuticals

has also entered into an alliance

with the Caribbean countries

and plans to penetrate the EU

market by the year 2020.

HEALTHCARE

Synokem

Pharmaceuticals

BUILDING A HEALTHY INDIA

Putting strong emphasis on providing unmatched quality

products at competitive rates with timely delivery and

unmatched service, Synokem Pharmaceuticals has built

its reputation as a leading manufacturer, marketer,

exporter and government tenderer of pharmaceutical

products in India, while rapidly becoming a global player